These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
521 related items for PubMed ID: 10717776
1. Effect of low-dose oral contraceptives on androgenic markers and acne. Thorneycroft IH, Stanczyk FZ, Bradshaw KD, Ballagh SA, Nichols M, Weber ME. Contraception; 1999 Nov; 60(5):255-62. PubMed ID: 10717776 [Abstract] [Full Text] [Related]
3. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Moutos D, Smith S, Zacur H. Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446 [Abstract] [Full Text] [Related]
5. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Wiegratz I, Jung-Hoffmann C, Kuhl H. Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973 [Abstract] [Full Text] [Related]
7. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K. Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580 [Abstract] [Full Text] [Related]
11. Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms). DelConte A, Loffer F, Grubb GS. Contraception; 1999 Mar; 59(3):187-93. PubMed ID: 10382082 [Abstract] [Full Text] [Related]
12. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Wild RA, Demers LM, Applebaum-Bowden D, Lenker R. Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706 [Abstract] [Full Text] [Related]
13. Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives. Anderson FD. Acta Obstet Gynecol Scand Suppl; 1992 Aug; 156():15-21. PubMed ID: 1324552 [Abstract] [Full Text] [Related]
14. Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. Boyd RA, Zegarac EA, Posvar EL, Flack MR. Contraception; 2001 Feb; 63(2):71-6. PubMed ID: 11292470 [Abstract] [Full Text] [Related]
15. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Godsland IF, Crook D, Devenport M, Wynn V. Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185 [Abstract] [Full Text] [Related]
16. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration. Granger LR, Roy S, Mishell DR. Am J Obstet Gynecol; 1982 Nov 01; 144(5):578-84. PubMed ID: 6890312 [Abstract] [Full Text] [Related]